Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-29

Clinical Trial Update: In This Study, the Sponsor Would Like to Collaborate with Institution and Investigator to Aggregate Participants Data and to Pilot Its Software Algorithm Using Machine Learning and Threshold Based Methods for Predicting Exacerbations and Deterioration Within a 60 Days Period Post-discharge

View source ↗

Summary

This trial update describes a plan to collaborate with institutions to aggregate participant data and pilot Respiree's machine learning and threshold-based algo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Respiree Pte Ltd | Conditions: COPD | Status: NOT_YET_RECRUITING